Importance of Immunoglobulin Therapy for COVID-19 Patients with Lymphocytopenia

The global coronavirus disease 2019 (COVID-19) was announced as pandemic by the World Health Organization (WHO). With the increased number of infected and dead victims daily all over the world, it is become necessary need to stop or overcome its rapid spread. Despite the production of vaccine or even specified effective antivirus may take about six months to a year, Intravenous immunoglobulin (IVIg) may be clinically used as safe treatment to save and improve the quality of life of patients with a variety of immunodeficiency diseases such as lymphocytopenia, which is a common clinical feature in COVID- 19. This passive immunization may fight strongly against the virus and the survival of the patients could be kept.